AGP Picks
View all

AGP Executive Report

Last update: 8 hours ago

E.U. Travel Rules: The EU Entry/Exit System (EES) is now fully operational, replacing passport stamps with a digital record of non-EU short stays (up to 90 days in 180) plus facial images and fingerprints—so trips through Schengen borders may look different from before. U.S. Drone Tariffs: The Trump administration is using Section 232 to impose drone import tariffs up to 100% for heavier, more capable systems, with lower rates for some EU/Swiss-origin equipment—raising costs that could ripple into defense-linked tech supply chains. Weight Loss Drug Deal: Gan & Lee’s obesity/overweight GLP-1 injection rights in Europe (including Liechtenstein) have been sold to Menarini for up to about EUR726 million, with down payment and milestone payments plus royalties. Climate & Health Context: July 2026 tied with July 2024 as the hottest July on record, underscoring rising heat risks for public health. Local Safety & Trust: CENTCOM says recent reports about deaths or mental health crises aboard USS Abraham Lincoln are false, pointing to crew reenlistment rates and a recovered sailor. Health Tech Watch: The SEC is set to vote on “Regulation Crypto Assets,” aiming to create a tailored offering path for certain crypto investment contracts. Public Info Integrity: Forbes-branded fake sites, including “Forbes Liechtenstein,” are being flagged as AI-generated and paid-for, with the publisher taking action.

Note: AI summary from news headlines; neutral sources weighted more to help reduce bias in the result. Feedback is welcome. Please let us know if you have any comments or suggestions about the AGP Executive Report.

AGP Wire

fallback image
Jul. 28, 2026

The European releases its Summer 2026 edition

AGP

fallback image
Jul. 3, 2026

European Commission authorizes CinnaGen’s osteoporosis biosimilar Zandoriah in EU

AGP

fallback image
Jul. 2, 2026

American Swiss Foundation honors Adrian Keller at leadership dinner in Rüschlikon

AGP

fallback image
Jun. 24, 2026

Shufti, Evrotrust link identity checks to qualified signatures across EU onboarding

AGP


Perspectify logo Perspectify News

Learn about labels.

Labels
Left-wing Center-left Neutral Public Broadcaster Gov't Institution Center-right Right-wing Pro-Government Gov't Propaganda Indeterminate
filter

Filter

Source Label Filters

All labels are selected. Deselect any labels you want to hide from your feed.

Labels:

Left-wing
Center-left
Neutral
Public Broadcaster
Gov't Institution
Center-right
Right-wing
Pro-Government
Gov't Propaganda
Indeterminate
IMPACT Therapeutics grants Pharmanovia exclusive $488m rights to senaparib

IMPACT Therapeutics grants Pharmanovia exclusive $488m rights to senaparib

IMPACT Therapeutics Signs Exclusive License Agreement with Pharmanovia for Senaparib in Europe, Middle East and North Africa, Australia and New Zealand

IMPACT Therapeutics Signs Exclusive License Agreement with Pharmanovia for Senaparib in Europe, Middle East and North Africa, Australia and New Zealand


fallback image
Jul. 23, 2026

Healthcare Holding Switzerland Secures CHF 80 Million Syndicated Financing

GlobeNewswire, Inc.

fallback image
Jul. 24, 2026

NewAmsterdam Pharma and Menarini Group Receive Positive CHMP Opinion Recommending Marketing Authorization for Ubeslo® (Obicetrapib Monotherapy) and Evlarco® (Obicetrapib Plus Ezetimibe Fixed-Dose Combination)

GlobeNewswire, Inc.

fallback image
Aug. 14, 2026

Obyte Introduces Coop: A Decentralized Community System to Reward Meaningful Contributions

EIN Presswire

fallback image
Jul. 1, 2026

SERB Pharmaceuticals Completes Acquisition of European and MENA Rights to Idefirix® (imlifidase) from Hansa Biopharma

GlobeNewswire, Inc.

fallback image
May 19, 2026

SERB Pharmaceuticals to acquire European and MENA rights to Idefirix® (imlifidase) from Hansa Biopharma for €115 million

GlobeNewswire, Inc.

fallback image
May 18, 2026

New Memoranda pave the way for €50 million in investments in local development and public health

Government of Slovenia

More press releases

Video Stories

YouTube video thumbnail: Geography Now! Liechtenstein
Play
Geography Now! Liechtenstein
YouTube video thumbnail: Liechtenstein: Where Princes Reign Supreme
Play
Liechtenstein: Where Princes Reign Supreme
Affinity Group Publishing Logo Showcase
Discover Affinity Group Publishing
YouTube video thumbnail: How an Isolated Valley Became the World's Richest Country
Play
How an Isolated Valley Became the World's Richest Country
YouTube video thumbnail: Liechtenstein: Europe’s Last Absolute Monarchy
Play
Liechtenstein: Europe’s Last Absolute Monarchy

Video Title

Sign up for:

Health Monitor Liechtenstein

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.

globe

Explore More

Share this page:

Advanced Search Options

Search for:

Search scope:

Type:

Search in:

Date range:

The last

Sort by:

Sign up for:

Health Monitor Liechtenstein

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.